433 / 1498
When RT should be considered in “advanced-stage”?
•
With regimens with less excessive chemotherapy (ABVD X6;
BEACOPP X6, Stanford V)
•
Older patients (>50) tolerate intensive/long chemotherapy
poorly.
•
Patients with contra-indications for aggressive chemotherapy
•
Patients with predominantly bulky site(s)
•
Patients with residual disease after chemotherapy
•
Patients with residual disease that remain PET (+)
29